Interactive effects of cholecystokinin-8S and various serotonin receptor agonists on the firing activity of neostriatal neuronesin rats

Neuropeptides
K WilmsH Davidowa

Abstract

In rats anaesthetized with urethane single unit activity was extracellularly recorded in the neostriatum, and several drugs were microiontophoretically ejected. Separate administration of the sulfated octapeptide cholecystokinin (CCK-8S), serotonin (5-HT) or 8-OH-DPAT (a 5-HT(1A/7) receptor agonist) predominantly induced increases in the neuronal discharge rates (Wilcoxon test significant P<0.05), whereas the 5-HT(2A/2C) receptor agonist DOI affected only a few neurones and mainly reduced firing. After coadministration of CCK-8S and serotonin, activating effects also predominated (Wt P<0.05), but the neuronal responsiveness was significantly reduced (Chi2P<0.01). Similarly, concomitant application of CCK-8S and 8-OH-DPAT led to significant activation accompanied with a reduction of inhibitory effects. The block of serotonin- or 8-OH-DPAT-effects through specific 5-HT(1A) receptor antagonists implies the involvement of this receptor subtype within the striatum. In conclusion, concomitant action of CCK-8S and serotonin induces a mean level of neuronal activation that might promote normal function.

References

Apr 26, 2013·Experimental Brain Research·Philippe De DeurwaerdèreSylvia Navailles
Apr 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Diego CentonzeMauro Maccarrone

Citations

Sep 1, 1992·Archives of General Psychiatry·T R Insel
Feb 8, 1991·The Journal of Comparative Neurology·S N Schiffmann, J J Vanderhaeghen
Jan 1, 1990·Annals of the New York Academy of Sciences·G K AghajanianK Rasmussen
Jan 1, 1990·Neuroscience and Biobehavioral Reviews·R A Glennon
Jan 1, 1990·Annals of the New York Academy of Sciences·J M PalaciosG Mengod
Oct 1, 1988·Neuropeptides·C DurieuxB P Roques
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Mar 23, 1994·Annals of the New York Academy of Sciences·P Boden, G N Woodruff
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M RuatJ C Schwartz
Jan 4, 1998·Pharmacology, Biochemistry, and Behavior·N Maswood, L Uphouse
Oct 21, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J G Hensler, K A Truett
Dec 23, 1998·Psychopharmacology·K Krebs-Thomson, M A Geyer
Jan 14, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·W M Abi-SaabA Y Deutch
Mar 19, 1999·Journal of Neuroscience Research·N K NgP T Wong
Apr 8, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F X VollenweiderK L Leenders
May 23, 2000·Journal of Neural Transmission·M N SubhashS Jagadeesh

Related Concepts

Cholecystokinin
Pyridines
CCK-33
N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
Neostriatum
Serotonin Measurement
Piperazines
Neurons
Serotonin
Cholecystokinin Measurement

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.